The Rise of Biosimilars: Driving Cost Savings and Increased Access in US Hospitals

Written By Emily Carter , BS, CPT

Summary

  • Biosimilars have the potential to offer cost savings and increased access to specialized medical equipment in hospitals in the United States.
  • The procurement process for biosimilars involves evaluating efficacy, safety, and cost-effectiveness compared to the original biologic drug.
  • Effective inventory management is crucial for hospitals to ensure the availability of biosimilars and other specialized medical equipment while minimizing waste and expiration.

The Rise of Biosimilars

Biosimilars are biological products that are highly similar to and have no clinically meaningful differences from an existing FDA-approved reference product. These products have the potential to offer cost savings and increased access to specialized medical equipment in hospitals across the United States. With the expiration of patents on many biologic drugs, the market for biosimilars is rapidly growing, presenting new opportunities and challenges for Healthcare Providers.

Benefits of Biosimilars

There are several key benefits associated with the use of biosimilars in hospitals:

  1. Cost Savings: Biosimilars are typically priced lower than their reference biologic drugs, offering a more cost-effective treatment option for patients.
  2. Increased Access: With lower costs and greater availability, biosimilars can help expand patient access to specialized medical equipment and treatments.
  3. Competition: The introduction of biosimilars into the market can create competition, driving down prices and potentially leading to further cost savings for hospitals and patients.

Challenges of Biosimilars

While biosimilars offer significant benefits, there are also challenges associated with their procurement and use in hospitals:

  1. Evaluation: Healthcare Providers must carefully evaluate the efficacy, safety, and cost-effectiveness of biosimilars compared to the original biologic drug to ensure patient outcomes are not compromised.
  2. Regulatory Hurdles: The regulatory approval process for biosimilars can be complex and time-consuming, requiring thorough clinical data and evidence of similarity to the reference product.
  3. Education: Healthcare professionals and patients may require education and training to understand the differences between biosimilars and biologic drugs and feel confident in their use.

Procurement Process for Biosimilars

The procurement process for biosimilars in hospitals involves several key steps to ensure the safe and efficient acquisition of these specialized medical products:

Evaluation and Selection

Healthcare Providers must carefully evaluate biosimilars based on factors such as efficacy, safety, and cost-effectiveness compared to the original biologic drug. This process may involve reviewing clinical data, consulting with experts, and conducting thorough cost analyses.

Negotiation and Contracting

Once a biosimilar has been selected, hospitals may negotiate pricing and contract terms with manufacturers or suppliers to secure favorable terms. This may involve leveraging purchasing power, seeking volume discounts, and exploring long-term partnership opportunities.

Procurement and Distribution

After an agreement is reached, hospitals can proceed with the procurement and distribution of biosimilars. This may involve working with group purchasing organizations (GPOs), distributors, or specialty pharmacies to ensure timely delivery and proper storage of these specialized medical products.

Inventory Management for Biosimilars

Effective inventory management is crucial for hospitals to ensure the availability of biosimilars and other specialized medical equipment while minimizing waste and expiration. Several key strategies can help Healthcare Providers optimize their inventory management practices:

Forecasting and Demand Planning

Healthcare Providers can use forecasting and demand planning tools to predict the usage of biosimilars and other specialized medical equipment accurately. This can help hospitals adjust their inventory levels, reorder quantities, and storage capacity to meet patient needs efficiently.

Storage and Handling

Proper storage and handling of biosimilars are essential to maintain their integrity and efficacy. Hospitals must adhere to specific storage requirements, such as temperature control, light exposure, and contamination prevention, to ensure the quality of these specialized medical products.

Expiration Management

Healthcare Providers must actively manage the expiration dates of biosimilars and other medical equipment to minimize waste and ensure patient safety. This may involve implementing first-in, first-out (FIFO) inventory rotation, tracking expiration dates, and disposing of expired products responsibly.

Quality Assurance and Regulatory Compliance

Hospitals must comply with quality assurance standards and regulatory requirements when managing biosimilars and other specialized medical equipment. This includes conducting regular audits, inspections, and documentation to ensure adherence to best practices and guidelines set by regulatory agencies.

Conclusion

Biosimilars have the potential to transform the procurement process and inventory management of specialized medical equipment in hospitals in the United States. By carefully evaluating these products, negotiating favorable terms, and implementing effective inventory management strategies, Healthcare Providers can increase patient access, reduce costs, and optimize patient outcomes.

a-gloved-hand-holding-two-purple-top-tubes-with-blood-speciments

Disclaimer: The content provided on this blog is for informational purposes only, reflecting the personal opinions and insights of the author(s) on the topics. The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician. Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. No contributors to this web site make any representations, express or implied, with respect to the information provided herein or to its use. While we strive to share accurate and up-to-date information, we cannot guarantee the completeness, reliability, or accuracy of the content. The blog may also include links to external websites and resources for the convenience of our readers. Please note that linking to other sites does not imply endorsement of their content, practices, or services by us. Readers should use their discretion and judgment while exploring any external links and resources mentioned on this blog.

Related Videos

Emily Carter , BS, CPT

Emily Carter is a certified phlebotomist with over 8 years of experience working in clinical laboratories and outpatient care facilities. After earning her Bachelor of Science in Biology from the University of Pittsburgh, Emily became passionate about promoting best practices in phlebotomy techniques and patient safety. She has contributed to various healthcare blogs and instructional guides, focusing on the nuances of blood collection procedures, equipment selection, and safety standards.

When she's not writing, Emily enjoys mentoring new phlebotomists, helping them develop their skills through hands-on workshops and certifications. Her goal is to empower medical professionals and patients alike with accurate, up-to-date information about phlebotomy practices.

Previous

Equitable Distribution of Hospital Supplies and Equipment in Underserved Populations

Next

Trends in Hospital Supply Management: Digital Solutions, Automation, and Sustainability